Revenue
2019
2020
2021
2022
2023
2024
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue | ¥206.80B | ¥192.38B | ¥140.79B | ¥173.83B | ¥141.74B | ¥154.79B |
| Research & development | ¥7.75B | ¥8.92B | ¥9.54B | ¥9.41B | ¥6.32B | ¥5.35B |
| Operating income | ¥1.94B | −¥5.74B | −¥17.82B | −¥48.44B | −¥13.79B | −¥8.01B |
| EBITDAderived | ¥5.11B | −¥1.49B | −¥12.68B | −¥42.40B | −¥8.52B | −¥4.00B |
| Net income | ¥1.26B | ¥493.5M | −¥23.78B | −¥49.34B | −¥10.51B | −¥9.73B |
| Basic EPSper diluted share | CN¥1.03 | -CN¥0.41 | -CN¥20.38 | -CN¥76.04 | -CN¥100.10 | -CN¥96.62 |
| Diluted EPSper diluted share | CN¥1.01 | -CN¥0.41 | -CN¥20.38 | -CN¥76.04 | -CN¥100.10 | -CN¥96.62 |